Evidence map›Paper›PMID 22304968›Full record

Trial reportPsychosomatics

Use of complementary and alternative medicine in a large sample of anxiety patients.

Alexander Bystritsky, Sarit Hovav, Cathy Sherbourne, Murray B Stein, Raphael D Rose, Laura Campbell-Sills, Daniela Golinelli, Greer Sullivan, Michelle G Craske, Peter P Roy-Byrne

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychosomatics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00347269 (Coordinated Anxiety Learning and Management), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00347269 phase4completednot on this map

Coordinated Anxiety Learning and Management (CALM): Improving Primary Care Anxiety Outcomes

TypeinterventionalSponsorUniversity of WashingtonRan2006 to 2009Enrolled1,004ConditionsPost-traumatic Stress Disorder, Generalized Anxiety Disorder, Panic Disorder, Social Anxiety DisorderArmsCognitive-behavioral therapy, Psychotropic medication optimization, Treatment as Usual
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2016
    Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexander BystritskyDepartment of Psychiatry and Biobehavioral Science, University of California, Los Angeles, CA 90095, USA. abystritsky@mednet.ucla.edu
Sarit Hovav
Cathy Sherbourne
Murray B Stein
Raphael D Rose
Laura Campbell-Sills
Daniela Golinelli
Greer Sullivan
Michelle G Craske
Peter P Roy-Byrne

Funding

CALM: IMPROVING PRIMARY CARE ANXIETY OUTCOMESU01MH070018 · NIMH · RAND CORPORATION · PI SHERBOURNE, CATHY D · 2005 to 2009
$3.1M
NIMH NIH HHS U01 MH070018
6 · The paper itself

Abstract

objectiveTo examine a large sample of patients with anxiety and the association between types of complementary and alternative treatments that were used, demographic variables, diagnostic categories, and treatment outcomes.

methodCross-sectional and longitudinal survey during the Coordinated Anxiety Learning and Management (CALM) study that assessed this intervention against the Usual Care in a sample of patients with anxiety recruited from primary care. Interviewer-administered questionnaires via a centralized telephone survey by blinded assessment raters. The interviews were done at baseline, 6, 12, and 18 months of the study. A total of 1004 adults ages 18-75 who met DSM-IV criteria for Generalized Anxiety Disorder (GAD), Panic Disorder, Social Anxiety Disorder, or Post-Traumatic Stress Disorder. We assessed medication/herbal use, the use of any alternative therapies, and combined Complementary and Alternative Medicine (CAM) use.

resultsWe found an extensive (43%) use of a variety of CAM treatments that is consistent with previous study results in populations with anxiety. Only a few significant demographic or interventional characteristics of CAM users were found. Users most often had a diagnosis of GAD, were older, more educated, and had two or more chronic medical conditions. CAM users who had a 50% or more drop in anxiety scores over 18 months were less likely to report continued use of alternative therapies.

conclusionsThe study confirms the importance of awareness of CAM use in this population for possible interference with traditional first-line treatments of these disorders, but also for finding the best integrative use for patients who require multiple treatment modalities.

Indexed as

Primary Health CareAdolescentAdultAge DistributionAnxiety DisordersAttitude to HealthCognitive Behavioral TherapyCombined Modality TherapyComplementary TherapiesCross-Sectional StudiesFemaleHumansLogistic ModelsLongitudinal StudiesMaleMiddle Aged

Identifiers

PMID22304968
PMCPMC4014348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.